Where can I buy shares of Tak?
Shares of TAK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is TransAct Technologies (TAC) stock a buy or sell?
TransAct Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $19.50, TransAct Technologies has a forecasted upside of 100.0% from its current price of $9.75.
Does TransAct Technologies stock pay a dividend?
TransAct Technologies does not currently pay a dividend. TransAct Technologies does not have a long track record of dividend growth. In the past three months, TransAct Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $195,697.00 in company stock.
How much is a share of Takeda worth?
One share of TAK stock can currently be purchased for approximately $14.52. How much money does Takeda Pharmaceutical make? Takeda Pharmaceutical has a market capitalization of $45.95 billion and generates $30.17 billion in revenue each year. The company earns $3.53 billion in net income (profit) each year or $1.58 on an earnings per share basis.
See more
Is Takung Art a buy?
The Takung Art Company. Ltd stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock.
Why did TKAT stock go up?
What happened. Shares of Takung Art (NYSEMKT: TKAT) soared 989.7% in March, according to data from S&P Global Market Intelligence. Excitement built around non-fungible tokens (NFTs) last month, and the Hong Kong-based online art platform's stock soared as a result.
What does Takung Art Co Ltd do?
Takung Art is an online trading platform that provides a secure and easy way for art collectors and investors to acquire shared ownership in Asian and other fine art – including paintings, calligraphies, jewelry, and precious gems - and participate in the booming Asian art market without fear of price manipulation and ...
Should I buy or sell Takeda Pharmaceutical stock right now?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Takeda Pharmaceutical in the last year. There are curren...
How has Takeda Pharmaceutical's stock performed in 2022?
Takeda Pharmaceutical's stock was trading at $13.63 at the beginning of the year. Since then, TAK shares have decreased by 1.8% and is now trading...
When is Takeda Pharmaceutical's next earnings date?
Takeda Pharmaceutical is scheduled to release its next quarterly earnings announcement on Friday, July 29th 2022. View our earnings forecast for T...
How were Takeda Pharmaceutical's earnings last quarter?
Takeda Pharmaceutical Company Limited (NYSE:TAK) announced its earnings results on Wednesday, May, 11th. The company reported $0.38 earnings per sh...
Is Takeda Pharmaceutical a good dividend stock?
Takeda Pharmaceutical(NYSE:TAK) pays an annual dividend of $0.33 per share and currently has a dividend yield of 2.48%. The dividend payout ratio o...
What guidance has Takeda Pharmaceutical issued on next quarter's earnings?
Takeda Pharmaceutical issued an update on its FY 2022 earnings guidance on Wednesday, June, 8th. The company provided earnings per share (EPS) guid...
Who are Takeda Pharmaceutical's key executives?
Takeda Pharmaceutical's management team includes the following people: Mr. Christophe Weber , Pres, CEO & Representative Director (Age 56, Pay $...
Who are some of Takeda Pharmaceutical's key competitors?
Some companies that are related to Takeda Pharmaceutical include Bristol-Myers Squibb (BMY) , Sanofi (SNY) , GSK (GSK) , CSL (CSLLY) , Zoetis...
What other stocks do shareholders of Takeda Pharmaceutical own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Takeda Pharmaceutical investors own include Cisco Systems...
When will Takeda report 2021?
What is FIN 524?
OSAKA, Japan, June 29, 2021--Takeda Pharmaceutical Company Limited ("Takeda") (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2021 (the "Annual Report") with the U.S. Securities and Exchange Commission (the "SEC").
What is Takeda Pharmaceutical's stock symbol?
Finch Therapeutics Group Inc (NASDAQ: FNCH) announced that Takeda Pharmaceutical Company Limited (NYSE: TAK) has elected to take the lead on the development of FIN-524, now known as TAK-524, in ulcerative colitis.
What other stocks do shareholders of Takeda Pharmaceutical own?
Takeda Pharmaceutical trades on the New York Stock Exchange (NYSE) under the ticker symbol "TAK."
What guidance has Takeda Pharmaceutical issued on next quarter's earnings?
Based on aggregate information from My MarketBeat watchlists, some companies that other Takeda Pharmaceutical investors own include Cisco Systems (CSCO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Pfizer (PFE), Verizon Communications (VZ), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), AT&T (T) and Abbott Laboratories (ABT).
Does Takeda Pharmaceutical have any subsidiaries?
Takeda Pharmaceutical updated its FY 2021 earnings guidance on Monday, February, 21st. The company provided EPS guidance of $3.610-$3.610 for the period. The company issued revenue guidance of $30.48 billion-$30.48 billion.
What is MarketBeat community ratings?
The following companies are subsidiares of Takeda Pharmaceutical: ARIAD Pharmaceuticals, Baxalta Manufacturing S.à r.l., IDM Pharma Inc., Intellikine, Inviragen, LigoCyte Pharmaceuticals, Meritage Pharma Inc., Millennium Pharmaceuticals, Millennium Pharmaceuticals Inc., Nihon Pharmaceutical Co. Ltd., Nycomed Pharma, PvP Biologics, Shire, Shire ViroPharma LLC, Takeda (China) Holdings Co. Ltd., Takeda AS, Takeda Austria GmbH, Takeda Bio Development Center, Takeda California Inc., Takeda Consumer Healthcare Company Limited, Takeda Development Center Americas Inc., Takeda Development Center Asia Pte. Ltd., Takeda Development Centre Europe Ltd., Takeda Distribuidora Ltda., Takeda France S.A.S., Takeda GmbH, Takeda Ireland Limited, Takeda Italia S.p.A., Takeda Pharma A/S, Takeda Pharmaceutical (China) Company Limited, Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals Korea Co. Ltd., Takeda Pharmaceuticals Limited Liability Company, Takeda Pharmaceuticals U.S.A. Inc., Takeda UK Limited, Takeda Vaccines Inc., Takeda Vaccines Pte. Ltd., and TiGenix.
When will Takeda release its earnings?
MarketBeat's community ratings are surveys of what our community members think about Takeda Pharmaceutical and other stocks. Vote “Outperform” if you believe TAK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TAK will underperform the S&P 500 over the long term. You may vote once every thirty days.
Is Takeda Pharmaceutical a good dividend stock?
Takeda Pharmaceutical is scheduled to release its next quarterly earnings announcement on Friday, July 30th 2021. View our earnings forecast for Takeda Pharmaceutical.
TAK Depositary Receipt Chart
Takeda Pharmaceutical pays an annual dividend of $0.66 per share and currently has a dividend yield of 4.39%. TAK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Takeda Pharmaceutical is 41.77%. This payout ratio is at a healthy, sustainable level, below 75%.
Ideas
Get $150 worth of Bitcoin from TradeStation Crypto with a new account. Start trading
Profile
30 within month 50+ within year Takeda has made significant moves in the development of it's global pipeline. From the MASSIVE moves with various COVID vaccine manufacturers, to acquiring smaller Immunology biotech startups, and increase in Boston research sphere. I am the most bullish on Takeda purely from a fundamental standpoint.
How Much Of TransAct Technologies Incorporated (NASDAQ:TACT) Do Institutions Own?
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products.
When will Transact release results?
The big shareholder groups in TransAct Technologies Incorporated ( NASDAQ:TACT ) have power over the company. Large...
What is Transact Technologies?
TransAct Technologies Incorporated (Nasdaq: TACT), a global leader in software-driven technology and printing solutions for high-growth markets, announced today that it will release its first quarter 2021 results after the market closes on Thursday, May 6, 2021, and will host a conference call and simultaneous webcast at 4:30 p.m. ET that day. Both the call and webcast are open to the general public.
When is Transact's earnings call 2021?
TransAct Technologies Incorporated (Nasdaq: TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and printing solutions for high-growth markets, today reported preliminary operating results for the quarter ended March 31, 2021.
When will Boha be released?
NEW YORK, NY / ACCESSWIRE / May 6, 2021 / TransAct Technologies, Inc. (NASDAQ:TACT) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time.
What is TransAct Technologies' stock price today?
HAMDEN, Conn., September 28, 2021--TransAct® Technologies Incorporated (Nasdaq: TACT) ("TransAct" or "the Company"), a global leader in software-driven technology and printing solutions for high-growth markets, today announced that it will debut the BOHA!® Work Station and BOHA! software for convenience stores’ fresh food operations at the National Association of Convenience Stores ("NACS 2021") on October 5-8, 2021 in Chicago, Illinois. BOHA! is the industry’s first single-vendor solution to co
What other stocks do shareholders of TransAct Technologies own?
One share of TACT stock can currently be purchased for approximately $9.80.
What is marketbeat ratings?
Based on aggregate information from My MarketBeat watchlists, some companies that other TransAct Technologies investors own include Allena Pharmaceuticals (ALNA), Energy Transfer (ET), Palatin Technologies (PTN), RedHill Biopharma (RDHL), Veru (VERU), British American Tobacco (BTI), Cerecor (CERC), Enterprise Products Partners (EPD), Genocea Biosciences (GNCA) and Intel (INTC).
When is Transact earnings call?
MarketBeat's community ratings are surveys of what our community members think about TransAct Technologies and other stocks. Vote “Outperform” if you believe TACT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TACT will underperform the S&P 500 over the long term. You may vote once every thirty days.
When will Transact Technologies release its earnings?
TransAct Technologies will be holding an earnings conference call on Tuesday, August 3rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 844-512-2921 with passcode "8684634".
Is Transact Technologies a buy?
TransAct Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021. View our earnings forecast for TransAct Technologies.
Does Transact pay dividends?
TransAct Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
